Publications

5674 Results

Ten-year survival in patients with metastatic (M+) prostate cancer (CAP): analysis of Southwest Oncology Group (SWOG) 8894.

Authors
ED Crawford;J Faulkner;IM Thompson;M Eisenberger;C Tangen;M Hussain
Journal / Conference
Journal of Urology 167(4)Suppl:304(#1202)
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model.

Authors
RJ Tuthill;JM Unger;PY Liu;LE Flaherty;VK Sondak
Journal / Conference
American Journal of Clinical Pathology 118(4):504-511
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8049

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study

Authors
JE Anderson;KJ Kopecky;CL Willman;D Head;MR O'Donnell;FW Luthardt;TH Norwood;IM Chen;SP Balcerzak;DB Johnson;FR Appelbaum
Journal / Conference
Blood 100(12):3869-3876
Year
2002
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9333

Phase 3 randomized trial of 12 versus 3 months of single-agent paclitaxel in patients with advanced ovarian cancer who attained a clinically defined complete response to platinum/paclitaxel-based chemotherapy, a Southwest Oncology Group trial

Authors
M Markman;PY Liu;S Wilczynski;BJ Monk;L Copeland;DS Alberts
Journal / Conference
Gynecologic Oncology 84:479(#1)
Year
2002
Research Committee(s)
Gynecologic
Study Number(s)
S9701

Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study

Authors
SR Wolman;H Gundacker;FR Appelbaum;ML Slovak
Journal / Conference
Blood 100(1):29-35
Year
2002
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9007

Biochemical modulation of 5-fluorouacil through dihydropyrimidine dehydrogenase inhibition: a Southwest Oncology Group phase II trial of eniluracil and 5-fluorouracil in advanced resistant colorectal cancer.

Authors
CG Leichman;K Chansky;JS Macdonald;MA Doukas;GT Budd;JK Giguere;JL Abbruzzese
Journal / Conference
Investigational New Drugs 20:419-424
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
S9635

Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment.

Authors
D Heddens;DS Alberts;EV Hannigan;SD Williams;D Garcia;DJ Roe;J Bell;RD Alvarez
Journal / Conference
Gynecologic Oncology 86:239-243
Year
2002
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412, SWOG-8501 (INT-0051)

Failure of beta-globin gene detection does not predict non-amplification of DNA in JH/Bcl-2 PCR Analysis: insights from a national follicular lymphoma clinical trial

Authors
G Fan;RM Braziel;T Grogan
Journal / Conference
Modern Pathology 15(1):240a(#1002)
Year
2002
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Gene expression profiling in laser microdissected normal follicular mantles, mantle cell lymphoma (MCL), and blastoid variant of mantle cell lymphoma

Authors
S de Vos;U Krug;WK Hofman;GS Pinkus;SH Swerdlow;W Wachsman;T Grogan;C Yue;HP Koeffler;JW Said
Journal / Conference
Modern Pathology 15(1):237a(#991)
Year
2002
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5 year follow-up, phase II SWOG study 9109

Authors
IJ Powell;CM Tangen;GJ Miller;BA Lowe;G Haas;PR Carroll;MB Osswald;R deVere-White;IM Thompson Jr;ED Crawford
Journal / Conference
Journal of Urology 168:2016-2019
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9109